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Background: Acute toxicity is usually defined as adverse changes occurring immediately or a short time after the 
start of oncological treatment. 
Material an Methods: Cross-sectional retrospective study performed with head and neck cancer patients who un-
derwent radiotherapy from 2013 to 2016.
Results: Ten (1.2%) patients developed SOMs during radiotherapy, most (80%) of which were men with a mean 
age of 59.5 years at diagnosis. SOMs mainly affected the floor of the mouth (60%) between the fourth and the sixth 
weeks of radiation therapy. All lesions were asymptomatic and spontaneously ruptured approximately 9 days after 
diagnosis.
Conclusions: Although rare, SOMs may be regarded as an acute oral toxicity of head and neck radiotherapy.




Head and neck squamous cell carcinoma (HNSCC) is 
one of the leading causes of cancer-related morbidity 
and mortality, with approximately 500,000 new cases 
diagnosed yearly worldwide, most of which are recog-
nized in advanced stages of disease progression. HN-
SCC treatment involves surgery, chemotherapy (CT), 
and head and neck radiotherapy (HNRT). More recent-
ly, concomitant HNRT and CT (chemoradiation, CRT) 
have significantly improved the 5-year survival rates of 
HNSCC patients. However, although effective in tumor 
control, CRT is associated with a myriad of debilitating 
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toxicities to non-targeted tissues surrounding the tumor 
and a consequent reduction in the quality of life of can-
cer survivors (1,2). 
Acute toxicity is usually defined as adverse changes 
occurring immediately or a short time after the start 
of medical treatment. In the case of HNRT, acute oral 
toxicities include mucositis, hyposalivation, dysgeusia, 
dysphagia and opportunistic infection mainly caused 
by Candida albicans and Herpes simplex virus. Oral 
chronic toxicity, in turn, can be defined as an adverse 
event occurring 3 months after the conclusion of HNRT 
that might persist over a long period of time (even for the 
rest of the patient’s life). The more relevant oral chronic 
toxicities secondary to HNRT include hyposalivation, 
trismus, radiation-related caries, osteoradionecrosis 
(ORN) and dysphagia, which eventually form a cluster 
of oral symptoms with the potential to impair overall 
oral function and also to negatively impact on patients’ 
quality of life (1,3,4).
A complete understanding of head and neck compli-
cations following cancer therapies is paramount to ef-
fectively characterize the burden of HNRT-related tox-
icities. In this scenario, underestimating oral toxicities 
may result in inappropriate care for HNSCC patients. 
Remarkably, there is still a lack of information regard-
ing oral toxicities that might occur during cancer thera-
py in HNSCC patients (3). 
Of note, conventional mucoceles were previously de-
scribed in different anatomic sites of patients who con-
cluded HNRT, including the maxillary sinus (5,6); the 
sphenoidal sinus (7-10); and the ethmoidal sinus (10,11). 
Therefore, the aim of this study was to describe an 
original case series of HNSCC patients who developed 
superficial oral mucoceles (SOM) during HNRT. 
Material and Methods
This was a cross-sectional retrospective study based on 
HNSCC patients submitted to HNRT at a single institu-
tion, from January 2013 to October 2016. The research 
protocol was approved by the Ethics Committee of the 
University of Sao Paulo Medical School (number 882.731). 
All patients included in this study received dental treat-
ment and oral hygiene instructions before the start of 
HNRT. Information regarding oral toxicities during 
cancer therapy was recorded following the institutional 
protocol of daily systematic oral examinations dur-
ing the course of HNRT. The electronic charts of the 
patients were retrieved for clinical and epidemiologic 
characterization, including patient’s age, gender, tumor 
location, and cancer treatment protocols, among others.
Results
Ten (1.2%) out of 834 HNSCC patients evaluated during 
the study period developed SOMs. None of the patients 
presented SOMs or any other soft tissue oral lesions be-
fore the start of HNRT. Eight (80%) patients were male 
and 2 (20%) female, with a mean age of 59.5 years at 
diagnosis of SOM. All patients presented an advanced 
clinical stage of disease (III/IV) at cancer diagnosis and 
a marked history of tobacco (100%) and alcohol (100%) 
consumption. 
All selected patients were treated with 3D conformal 
tri-dimensional radiotherapy in 6mV linear accelerators 
on Synergy Platform (Elekta AB, Stockholm, Sweden), 
with radiation doses ranging from 60 to 70 Gy. Five 
(50%) patients [primary tumors were located in the oro-
pharynx (20%), buccal mucosa (10%), palate (10%) and 
base of the tongue 1 (10%)] were treated with induction 
chemotherapy (paclitaxel+cisplatin) in combination 
with concurrent CRT (cisplatin), 2 (20%) oropharynx 
squamous cell carcinoma patients were treated with 
isolated RT, 1 (10%) patient (floor of the mouth squa-
mous cell carcinoma) was treated by the combination of 
induction chemotherapy (paclitaxel+cisplatin) and RT, 
1 (10%) patient (retromolar squamous cell carcinoma) 
was treated by surgery and adjuvant RT and 1 (10%) pa-
tient (larynx squamous cell carcinomas) was managed 
with surgery and adjuvant CRT (cisplatin). 
Four (40%) patients developed SOM in the fourth week 
of radiation therapy, 1 (10%) in the fifth week, 2 (20%) 
in the sixth week, and 3 (30%) in the seventh week of 
HNRT. SOM lesions were predominantly observed in 
the floor of the mouth (60%) and none of the patients 
reported pain associated with the lesions. At diagno-
sis, SOM vesicles measured 0.7 cm in diameter, rang-
ing from 0.3 a 3 cm. All SOM lesions spontaneously 
ruptured and regressed after a mean time of 9 days fol-
lowing onset (clinical diagnosis), ranging from 7 to 21 
days. Although asymptomatic, 1 (10%) patient reported 
discreet and self-limiting pain (after 7 days) following 
the spontaneous rupture of the lesion associated with 
ulceration.
Detailed demographic and clinicopathological informa-
tion concerning the patients included in this study are pre-
sented in Table 1. Illustrative clinical images of the SOM 
cases are presented in Figures 1-3.
Discussion
Eveson (12) originally described SOM in 1988 as small, 
translucent, subepithelial vesicles affecting the oral 
mucosa. In general, these lesions are more commonly 
observed in female patients over the age of 30 years old 
and most often affecting the soft palate and the buccal 
mucosae (13-15). Conversely, in the present case series, 
the majority of the patients were elderly males with 
most of the lesions affecting the floor of the mouth. The 
different demographic pattern of the present series was 
probably influenced by the fact that this is a series of 
SOM affecting HNSCC patients who are typically com-
posed of elderly male populations (16). It is also relevant 
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to mention that the patients included in this study were 
typical in terms of cancer demographic features, in the 
sense that most of them presented oral cavity and oral 
pharynx advanced squamous cell carcinomas, which 
were treated by HNRT, exclusively or combined with 
surgery or CT (17).
Recently, Keshet et al. (18) reported two cases of SOM 
in patients who concluded HNRT. In this previous re-
port, both patients were female, and affected by ad-
Fig. 1. A, B and C. Multiple superficial oral mucoceles (arrows) affecting floor of the mouth, buccal mucosa and retromolar area 
(patient# 1). D. Two synchronous superficial oral mucoceles (arrows) on the right floor of the mouth (patient# 2). E. Superficial oral 
mucocele (arrow) on the left buccal mucosa (patient# 5). F. Superficial oral mucocele (arrow) affecting the right posterior floor of 
the mouth (patient# 6). G. Superficial oral mucocele (arrow) on the left posterior buccal mucosa (patient# 7). H. Superficial oral 
mucocele (arrow) on the right anterior floor of the mouth (patient# 8). I. Superficial oral mucocele (arrow) on the right alveolar 
ridge (patient# 9).
Fig. 2. A. Superficial oral mucocele (arrow), which developed on the fifth week of radiotherapy, affecting the left posterior floor of the 
mouth (patient# 3). B. Seven-day-spontaneous rupture of superficial oral mucocele displayed on figure 2. A resulting in an erythematous 
background (arrow).
vanced tongue squamous cell carcinoma. One of the 
patients presented three synchronous SOMs affecting 
the buccal and labial mucosa one month after the con-
clusion of isolated HNRT (6,500 cGy). The other pa-
tient presented multiple SOMs in the soft palate three 
months after the conclusion of adjuvant HNRT (total 
dose 6,400 cGy). In contrast to their results, herein we 
suggest that SOM may also develop as an acute oral tox-
icity of HNRT since the majority of the patients studied 
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Fig. 3. A. Superficial oral mucocele (arrow) on the right posterior floor of the mouth, which developed in the fourth week of radiotherapy 
(patient# 4). B. Seven-day-spontaneous rupture of superficial oral mucocele displayed on figure 3. A resulting in ulceration (arrow). C and D. 
Multiple superficial oral mucoceles developing on the lower lip in the seventh week of radiotherapy (patient# 9). E. A 3-week-follow-up image 
showing spontaneous partial rupture of lesions.  
developed SOM between the fourth and sixth weeks of 
radiation therapy (with cumulative doses ranging from 
4,000 cGy to 6,800 cGy). Possibly, this is the first evi-
dence of SOMs during the course of HNRT, which were 
recognized early because all patients included in this 
study were submitted to systematic oral evaluations 
throughout the course of HNRT, which is part of the 
oral care treatment protocols of our service.
SOM can present as single or multiple mucosae vesicles 
and often present as “short-lived lesions” because they 
frequently rupture and cause superficial painful ulcers 
(5,6,8). In the current case series, none of the patients 
reported SOM-associated pain and they were all un-
aware of the existence of these lesions. Most patients 
presented small single SOM lesions, all of which rup-
tured spontaneously in approximately 9 days, leading 
to a prompt healing process. Of note was one patient 
in whom the spontaneous rupture resulted in a discreet 
and transitory painful sensation and another patient 
who presented multiple SOMs that persisted for 3 weeks 
after the conclusion of HNRT.  
A recent study performed by Treister et al. (19) prospec-
tively evaluated 458 patients with oral chronic graft-
versus-host disease (cGVHD) aiming to characterize 
the clinical features of oral manifestations of cGVHD. 
Interesting, they reported a high incidence of mucoceles 
(43%) in patients with oral cGVHD and dryness. When 
taken together, these results suggest that mucoceles and 
SOM might be regarded as relevant in the context of 
cancer treatment-related oral lesions. 
In terms of etiopathogenesis, Jensen (20) suggested that 
the increased pressure caused by mucous plugs in the 
intraepithelial squamous-cell-lined portions of the mi-
nor salivary glands ducts could cause duct rupture and 
lead to the development of SOM. This original evidence 
that SOMs may be an early event in HNRT validates the 
above-mentioned hypothesis because it is well-known 
that ionizing radiation causes permanent damage to the 
major and minor salivary glands, reducing the salivary 
flow rate and changing the qualitative composition of sa-
liva; this initially becomes evident during the first week 
of HNRT and is clinically detectable by the presence 
of a highly viscous and mucous saliva (21-23). Hence, 
HNRT-related SOM may develop as a consequence of 
the increased viscosity of saliva, which increases the 
pressure in the ducts of minor salivary glands, causing 
duct rupture and sub-epithelial saliva accumulation. 
Although the current study seems to be original in de-
scribing the frequency and consistency of SOM in pa-
tients with HNSCC who underwent radiotherapy, it has 
limitations that should be considered in further clini-
cal studies, such as its retrospective nature, the limited 
number of patients and examiners. 
In conclusion, SOM should be considered an unrecog-
nized acute oral toxicity of HNRT. Future clinical stud-
ies are necessary to confirm the apparent self-limiting 
and non-painful behavior of these lesions and also to 
access the potential of SOM to rupture during HNRT 
and negatively impact the evolution of oral mucositis.
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